InheRET
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.0m | Grant | ||
$580k | Seed | ||
Total Funding | AUD4.0m |
Related Content
Recent News about InheRET
EditINHERET is a healthcare technology company specializing in personalized risk assessments for hereditary cancers. The company serves individuals and healthcare providers by offering tools to accurately identify genetic risks, fast track treatments, and save time and money. Operating in the healthcare and genetic testing market, INHERET's business model revolves around providing comprehensive guidelines and tools that help users build and maintain their personal and family health history. This information can be easily shared with providers and family members when needed. INHERET makes money through subscriptions and service fees for its risk assessment tools and genetic counseling services. The company prioritizes prevention strategies based on levels of risk, making adherence to these strategies more likely. INHERET's team includes experts in marketing, genetics, and clinical operations, ensuring a well-rounded approach to product development and customer service.
Keywords: hereditary cancer, genetic risk, personalized assessment, prevention strategies, healthcare technology, genetic counseling, risk identification, family health history, clinical operations, diagnostic testing.